Outcome Measures

Cross-source consensus on Outcome Measures from 1 sources and 5 claims.

1 sources · 5 claims

Dosage & preparation

Anxiety and depression are the primary outcomes. — Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals
The Short Mood and Feelings Questionnaire is the designated primary outcome measure for the future full trial. — Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals
Secondary outcomes include social support, mentalising, stigma, quality of life, loneliness, empowerment, acceptability, resource use, and randomisation acceptability. — Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals
Questionnaires are completed at baseline and 7-month follow-up and take about 25 minutes. — Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals
The minimum adherence threshold is watching at least one video story and creating at least one personal story. — Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals